510(k) K911345

HSV IN SITU DNA PROBE HYBRIDIZATION TEST KIT by Diagnostic Hybrids, Inc. — Product Code GQN

K911345 is an FDA 510(k) premarket notification submitted by Diagnostic Hybrids, Inc. for the device "HSV IN SITU DNA PROBE HYBRIDIZATION TEST KIT". The FDA issued a decision of Substantially Equivalent on June 17, 1991. The device falls under product code GQN (Antigen, Cf (Including Cf Control), Herpesvirus Hominis 1,2), a Class II device regulated under 21 CFR 866.3305. Diagnostic Hybrids, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 17, 1991
Date Received
March 27, 1991
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antigen, Cf (Including Cf Control), Herpesvirus Hominis 1,2
Device Class
Class II
Regulation Number
866.3305
Review Panel
MI
Submission Type